Screener
NeoGenomics NEO Contract Liabilities, Non-Current
Contract Liabilities, Non-Current at other companies
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Current contract assets (1) | $166 | — |
| Total contract assets | $166 | — |
| Current capitalized commissions (1) | $234 | $138 |
| Long-term capitalized commissions (2) | 265 | 36 |
| Total capitalized commissions | $499 | $174 |
| Current contract liabilities | $194 | $851 |
| Long-term contract liabilities (3) | 334 | 386 |
| Total contract liabilities | $528 | $1,237 |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's contract liabilities, non-current?
- NeoGenomics (NEO) reported contract liabilities, non-current of $334K in Q2 2026.
- How has NeoGenomics's contract liabilities, non-current changed year-over-year?
- NeoGenomics's contract liabilities, non-current decreased by 24.6% year-over-year, from $443K to $334K.
Ask your AI about NeoGenomics's contract liabilities, non-current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude